Effects of LPG and Ventilation Interventions on Reducing HAP and Improving Cardiopulmonary Health
Effects of Liquefied Petroleum Gas and Ventilation Interventions on Reducing Household Air Pollution From Solid Fuel Use and Improving Cardiopulmonary Health: A Multi-center, 2×2 Factorial Randomized Controlled Trial
1 other identifier
interventional
1,200
1 country
3
Brief Summary
The goal of this clinical trial is to evaluate the independent and synergistic effects of liquefied petroleum gas (LPG) substitution and improved ventilation on household air pollution (HAP) reduction and cardiopulmonary health. The main questions it aims to answer are:
- 1.Does LPG substitution or improved ventilation reduce HAP and improve cardiopulmonary health?
- 2.Would the combined intervention of LPG substitution and improved ventilation outperform single interventions?
- 3.What is the cost-effectiveness of such interventions, and are they sustainable?
- 4.Does the intervention reduce the incidence of cardiopulmonary clinical events?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2025
Longer than P75 for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 8, 2025
CompletedFirst Posted
Study publicly available on registry
June 5, 2025
CompletedStudy Start
First participant enrolled
July 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 30, 2029
March 17, 2026
February 1, 2026
4 years
May 8, 2025
March 15, 2026
Conditions
Outcome Measures
Primary Outcomes (5)
Change in the Number of Ultrafine particles (UFP)
Unit: particles/cm³, Measuring instrument: TSI NanoScan (TSI, USA), MicroPEM (PennEngineering, USA), Gillian5000 (Sensidyne, USA), Measurement method: Monitoring device sensors.
1 year, with follow-ups at 6, 12, 24, and 36 months
Change in the Concentrations of PM2.5
Unit: ug/m3, Measuring instrument: TSI NanoScan (TSI, USA), MicroPEM (PennEngineering, USA), Gillian5000 (Sensidyne, USA), Bbair (Yuanrui Environmental Protection Technology Co., Ltd, China) , Measurement method: Monitoring device sensors.
1 year, with follow-ups at 6, 12, 24, and 36 months
Change in the Heart Rate Variability (HRV) Measured by 12-lead ECG
Heart rate variability measured using standard 12-lead electrocardiogram (ECG). Measuring instrument: HeaLink heart rate sensor (Henan Link Medical Technology Co., Ltd., China), The time-domain indicators include:SDNN: Standard deviation of all normal-to-normal (NN) intervals over 24 hours / SDANN: Standard deviation of the average NN intervals calculated over 5-minute segments throughout 24 hours / RMSSD: Root mean square of successive differences between adjacent NN intervals over 24 hours. The frequency-domain indicators include: TP: Total power / LF: Low-frequency power / HF: High-frequency power / LF/HF: Ratio of low-frequency to high-frequency power.
1 year, with follow-ups at 6, 12, 24, and 36 months
Change in the Forced Vital Capacity (FVC)
Forced Vital Capacity measured using spirometer (HI105; Chestgraph, Japan). Units of Measure: Liters. Method of Measurement: Standardized spirometric testing protocol.
1 year, with follow-ups at 6, 12, 24, and 36 months
Change in the Forced Expiratory Volume in 1 Second (FEV1)
Forced Expiratory Volume in 1 Second measured using spirometer (HI105; Chestgraph, Japan). Units of Measure: Liters. Method of Measurement: Standardized spirometric testing protocol.
1 year, with follow-ups at 6, 12, 24, and 36 months
Secondary Outcomes (29)
Change in the Concentrations of Specific Chemical Components in Particulate Matter
1 year, with follow-ups at 6, 12, 24, and 36 months
Change in the Concentrations of Ozone (O₃)
1 year, with follow-ups at 6, 12, 24, and 36 months
Change in the Concentrations of Black Carbon (BC)
1 year, with follow-ups at 6, 12, 24, and 36 months
Change in the Systolic and Diastolic Blood Pressure
1 year, with follow-ups at 6, 12, 24, and 36 months
Change in the Fractional Exhaled Nitric Oxide (FeNO)
1 year, with follow-ups at 6, 12, 24, and 36 months
- +24 more secondary outcomes
Other Outcomes (45)
Change in the Serum Levels of Myocardial Function Biomarkers (BNP, NT-proBNP, Follistatin, Myoglobin, CK-MB, Troponin I, Troponin T)
1 year, with follow-ups at 6, 12, 24, and 36 months
Change in the Serum Levels of Club Cell Protein 16 (CC16) and Surfactant Protein D (SP-D)
1 year, with follow-ups at 6, 12, 24, and 36 months
Change in the Serum Levels of Blood Glucose, Insulin, and C-Peptide
1 year, with follow-ups at 6, 12, 24, and 36 months
- +42 more other outcomes
Study Arms (4)
A: Solid fuel + no ventilation (control).
OTHERSolid fuel + no ventilation facilities group: Continued use of solid fuels without installation of ventilation facilities and receipt of standardized health education. No LPG stoves or ventilation equipment will be provided during the intervention period. However, after the primary endpoint assessment at 12 months, all households in Group A will be provided with LPG stoves and ventilation facilities of equivalent specifications free of charge, along with health guidance. Phased cash compensation will be provided during the intervention period.
B: LPG + no ventilation.
EXPERIMENTALLiquefied petroleum gas (LPG) + no ventilation facilities group: Provided with LPG stoves and instructed to use them during cooking, with regular LPG supply throughout the intervention period. Participants will also receive standardized health education.
C: Solid fuel + ventilation.
EXPERIMENTALSolid fuel + ventilation facilities group: Continued use of solid fuels while being provided with ventilation facilities and instructed to use them during cooking. Electricity costs will be compensated during the intervention period. Participants will also receive standardized health education.
D: LPG + ventilation.
EXPERIMENTALLPG + ventilation facilities group: Provided with both LPG stoves and ventilation facilities and instructed to use both during cooking. Regular LPG supply and electricity cost compensation will be provided throughout the intervention period. Participants will also receive standardized health education.
Interventions
Installation and use of kitchen ventilation facilities (e.g., range hood) during cooking to reduce indoor air pollution exposure.
Households are provided with liquefied gas stoves and encouraged to use liquefied gas instead of solid fuels for cooking.
Households continue using traditional solid fuels (e.g., coal or biomass) for cooking according to their usual practices.
Households continue cooking without installing additional ventilation facilities during the intervention period.
Eligibility Criteria
You may qualify if:
- Aged 18-75 years;
- Local permanent residents with no plans for long-term travel or relocation within one year;
- Kitchen suitable for installation of ventilation facilities;
- Responsible for daily household cooking, cooking ≥5 times per week;
- To control for community penetration of pollution, households will be preferentially recruited in naturally ventilated, open villages, avoiding valleys or basins that hinder pollutant dispersion; preference for detached houses with ≥10 m distance from neighboring kitchens and well-sealed doors and windows.
- Secondary Participants:
- Elderly individuals aged 65-75 living with the primary participant;
- Children aged 3-6 living in the same household.
You may not qualify if:
- Clinical diagnosis of major chronic diseases such as severe respiratory diseases, cardiovascular diseases, malignant tumors, or end-stage renal disease;
- Pregnant or breastfeeding women;
- Current smokers or individuals with self-reported exposure to productive dust or other occupational hazards;
- Individuals who are unable to fully understand the study process or clearly express their own complaints, such as those with psychiatric disorders or severe neuroses, or who cannot cooperate with the study for other reasons.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Suiping County Health Center
Zhumadian, Henan, 4630000, China
Hong'an County Health Center
Huanggang, Hubei, 438000, China
Longhui County Health Center
Shaoyang, Hunan, 422000, China
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kuai Yu
Huazhong University of Science and Technology
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Research Fellow, Principal Investigator
Study Record Dates
First Submitted
May 8, 2025
First Posted
June 5, 2025
Study Start
July 1, 2025
Primary Completion (Estimated)
June 30, 2029
Study Completion (Estimated)
June 30, 2029
Last Updated
March 17, 2026
Record last verified: 2026-02